Japan: Relative Price Scores - Overbought and Oversold Companies - Calling 'Tops' & 'Bottoms'
RELATIVE PRICE SCORE - The Relative Price Score (RPS) measures stock price performance relative to TOPIX and is calculated by comparing the...
607 Views
Japan Pharma - Domestic Market and Long Listed Drug Exposure
The Japanese government recently announced its decision to initiate an ad-hoc price reduction of ~4.35%, to be levied in October 2019, this will...
989 Views
Japan Pharma - Top Picks
While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP) is a contrarian call in anticipation of value...
543 Views
Japan: Relative Price Score Update - Overbought and Oversold Companies
RELATIVE PRICE SCORE - The Relative Price Score (RPS) measures stock price performance relative to TOPIX and is calculated by comparing the current...
454 Views
Nippon Shinyaku 1H FY18 (YE Mar'19) Results - First Glance
Key highlights Overall sales increased ~8% to ¥53.5b due to Zalutia’s brisk domestic up-take (+17% to ¥5.8b) Uptravi ramp-up domestically (+138%...
418 Views